KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Inventory (2016 - 2025)

Historic Inventory for Exact Sciences (EXAS) over the last 12 years, with Q3 2025 value amounting to $164.8 million.

  • Exact Sciences' Inventory rose 2029.17% to $164.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $164.8 million, marking a year-over-year increase of 2029.17%. This contributed to the annual value of $162.4 million for FY2024, which is 2738.42% up from last year.
  • As of Q3 2025, Exact Sciences' Inventory stood at $164.8 million, which was up 2029.17% from $171.5 million recorded in Q2 2025.
  • Exact Sciences' Inventory's 5-year high stood at $176.6 million during Q1 2025, with a 5-year trough of $89.0 million in Q1 2021.
  • For the 5-year period, Exact Sciences' Inventory averaged around $127.5 million, with its median value being $127.4 million (2024).
  • Per our database at Business Quant, Exact Sciences' Inventory crashed by 259.77% in 2024 and then surged by 3737.53% in 2025.
  • Quarter analysis of 5 years shows Exact Sciences' Inventory stood at $105.0 million in 2021, then grew by 12.63% to $118.3 million in 2022, then increased by 7.79% to $127.5 million in 2023, then increased by 27.38% to $162.4 million in 2024, then increased by 1.48% to $164.8 million in 2025.
  • Its Inventory stands at $164.8 million for Q3 2025, versus $171.5 million for Q2 2025 and $176.6 million for Q1 2025.